Spectinomycin hydrochloride (trobicin) in the treatment of gonorrhea.
A clinical trial of spectinomycin (Trobicin) in acute gonorrhea in men was conducted in the Special Treatment Clinic at St. Michael's Hospital, Toronto, between August 1970 and February 1972. One hundred and forty men with clinical symptoms of gonorrhea received 2 g spectinomycin HC1 in a single dose intramuscularly. Of these, 101 returned seven days later for reassessment. Of these, 84 had a complete follow-up, with a bacteriological cure rate of 95 percent and a clinical cure rate of 91.8 percent. Therefore we conclude that spectinomycin HC1 (Trobicin; Upjohn) is a useful drug for the treatment of acute gonorrhea in males.
Linton
W T
WT
Hamilton-Smith
B
B
Persad
R L
RL
Mil Med. 1973 Jan;138(1):14-5
4264712
Can Med Assoc J. 1972 Nov 18;107(10):986-92
5082026
Br J Vener Dis. 1963 Sep;39:184-9
14071625
Br J Vener Dis. 1962 Sep;38:150-3
14000788
Br J Vener Dis. 1974 Aug;50(4):294-7
4279026
Br J Vener Dis. 1963 Mar;39:21-3
14000787